Ask the Experts: Provider Level Adjustments
Is there a best practice for handling provider level adjustments (PLBs) in electronic health record (EHR) systems?
Ask the Experts: Cost per day
Where can we find benchmarking data across other skilled nursing facilities related to costs per day for patient care?
4 strategies for improved Medicare Advantage plan performance
Positive operating margins in the Medicare Advantage segment require a shift toward more effectively managing Medicare populations by recognizing their unique needs and characteristics.
FY20 inpatient payment rule proposes changes to DSH, wage index
The proposed rule for Medicare inpatient payments could significantly affect uncompensated-care payment and wage adjustments.
Some Practices Leave Largest Bundle Program
Physician practices were more likely than other providers to depart from Medicare’s largest bundled payment program by the March 1 deadline to drop out, according to industry advisers.
340B Ruling: Good News for Some, Maybe
340B-eligible facilities are unsure of the fate of the 340B discount drug program as they await a U.S. District Court ruling on remedies that could further alter payments.
Ask the Experts: Behavioral Health Billing
We want to offer an intensive outpatient program (IOP) that provides group psychotherapy to patients who require a higher intensity of treatment than our outpatient setting provides. We need a thorough understanding of the billing process for the state of
Annual Hospital Costs for Opioid Overdose Patients Approaches $2 Billion
The average cost for an overdose patient who was treated and released totaled $504, but the average cost rose to $11,731 for those that were treated and admitted to a hospital.
The Time Is Now to Act on the 2019 Medicare Final OPPS Rule
Although some OPPS rule changes are being challenged by key stakeholders, hospitals and health systems should move forward with implementation and measure the financial impact.
Provider Payments Among Drug Costs Targeted by Congress
Jan. 29—Two provider payment systems were highlighted by members of Congress this week as areas in which policy changes are needed to control drug costs.